These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 8194136
1. Effects of glutathione precursors on human immunodeficiency virus replication. Simon G, Moog C, Obert G. Chem Biol Interact; 1994 Jun; 91(2-3):217-24. PubMed ID: 8194136 [Abstract] [Full Text] [Related]
2. Valproic acid reduces the intracellular level of glutathione and stimulates human immunodeficiency virus. Simon G, Moog C, Obert G. Chem Biol Interact; 1994 Jun; 91(2-3):111-21. PubMed ID: 7514959 [Abstract] [Full Text] [Related]
3. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Proc Natl Acad Sci U S A; 1991 Feb 01; 88(3):986-90. PubMed ID: 1704137 [Abstract] [Full Text] [Related]
5. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. J Gen Virol; 1996 Sep 01; 77 ( Pt 9)():1993-9. PubMed ID: 8810995 [Abstract] [Full Text] [Related]
6. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Roederer M, Staal FJ, Raju PA, Ela SW, Herzenberg LA, Herzenberg LA. Proc Natl Acad Sci U S A; 1990 Jun 01; 87(12):4884-8. PubMed ID: 2112750 [Abstract] [Full Text] [Related]
7. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice. Chen P, Bauer G, Mitchell J, Factor R, Markham R, Schwartz DH. AIDS; 1997 Jan 01; 11(1):33-41. PubMed ID: 9110073 [Abstract] [Full Text] [Related]
8. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function. Kameoka M, Tanaka Y, Ota K, Itaya A, Yoshihara K. Biochem Biophys Res Commun; 1999 Aug 19; 262(1):285-9. PubMed ID: 10448106 [Abstract] [Full Text] [Related]
9. HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines. Russo FO, Patel PC, Ventura AM, Pereira CA. Virus Res; 1999 Oct 19; 64(1):87-94. PubMed ID: 10500286 [Abstract] [Full Text] [Related]
10. Antioxidants inhibit stimulation of HIV transcription. Staal FJ, Roederer M, Raju PA, Anderson MT, Ela SW, Herzenberg LA, Herzenberg LA. AIDS Res Hum Retroviruses; 1993 Apr 19; 9(4):299-306. PubMed ID: 8512745 [Abstract] [Full Text] [Related]
12. A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. Weissman D, Poli G, Bousseau A, Fauci AS. Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2537-41. PubMed ID: 7681601 [Abstract] [Full Text] [Related]
13. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. Angel JB, Saget BM, Wang MZ, Wang A, Dinarello CA, Skolnik PR. J Interferon Cytokine Res; 1995 Jun 15; 15(6):575-84. PubMed ID: 7553227 [Abstract] [Full Text] [Related]
14. Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells. Prochaska HJ, Rubinson L, Yeh Y, Baron P, Polsky B. Mol Pharmacol; 1994 May 15; 45(5):916-21. PubMed ID: 8190108 [Abstract] [Full Text] [Related]
15. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Laughlin MA, Zeichner S, Kolson D, Alwine JC, Seshamma T, Pomerantz RJ, Gonzalez-Scarano F. Virology; 1993 Oct 15; 196(2):496-505. PubMed ID: 8372431 [Abstract] [Full Text] [Related]
16. N-acetylcysteine inhibits latent HIV expression in chronically infected cells. Roederer M, Raju PA, Staal FJ, Herzenberg LA, Herzenberg LA. AIDS Res Hum Retroviruses; 1991 Jun 15; 7(6):563-7. PubMed ID: 1931232 [Abstract] [Full Text] [Related]
18. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation. Stevens M, Balzarini J, Tabarrini O, Andrei G, Snoeck R, Cecchetti V, Fravolini A, De Clercq E, Pannecouque C. J Antimicrob Chemother; 2005 Nov 15; 56(5):847-55. PubMed ID: 16150861 [Abstract] [Full Text] [Related]
19. Comparison of N-acetylcysteine and l-2-oxothiazolidine-4-carboxylate as cysteine deliverers and glutathione precursors in human malignant melanoma transplants in mice. Dizdar N, Kullman A, Kågedal B. Cancer Chemother Pharmacol; 2000 Nov 15; 45(3):192-8. PubMed ID: 10663636 [Abstract] [Full Text] [Related]
20. The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Iimuro Y, Bradford BU, Yamashina S, Rusyn I, Nakagami M, Enomoto N, Kono H, Frey W, Forman D, Brenner D, Thurman RG. Hepatology; 2000 Feb 15; 31(2):391-8. PubMed ID: 10655262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]